跳至主要内容
临床试验/ACTRN12620000321943
ACTRN12620000321943尚未招募3 期

A double blind, randomised controlled pilot study of the effect of bisphosphonates versus placebo on parameters associated with fracture risk in patients on dialysis.

Westmead Hospital Research and Education Network0 个研究点目标入组 114 人开始时间: 2020年3月9日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • age 50 and over
  • Satellite haemodialysis

排除标准

  • Planned parathyroid surgery
  • Planned living related kidney transplant surgery within 12 months
  • Active non skin malignancy
  • Bilateral hip replacement making DXA hip bone mineral density impossible and hip structural analysis impossible
  • Gastro oesophageal reflux or gastritis or peptic ulcer disease symptoms that are not controlled with regular medications
  • A serum parathyroid hormone (PTH) level less than 2 times the upper normal range of the intact-PTH assay
  • A serum alkaline phosphatase (ALP) level below the normal lower range
  • Inability to provide informed consent

研究者

发起方
Westmead Hospital Research and Education Network

相似试验